ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,462Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 670

$1.25M Total Retail Price of All Prescriptions

Rank: 11 out of 670

986 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 986 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 986 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 20,855 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
SIMVASTATIN 966 882 1 4
LEVOTHYROXINE SODIUM 816 703 2 2
FUROSEMIDE 789 732 3 6
OMEPRAZOLE 682 662 4 5
AMLODIPINE BESYLATE 644 614 5 7
METOPROLOL TARTRATE 594 541 6 9
ATENOLOL 590 526 7 17
HYDROCODONE-ACETAMINOPHEN 589 503 S3 8 1
LISINOPRIL 491 436 9 3
POTASSIUM CHLORIDE 449 409 10 16
ATORVASTATIN CALCIUM 392 338 11 15
WARFARIN SODIUM 359 343 12 13
METFORMIN HCL 357 279 13 8
HYDROCHLOROTHIAZIDE 356 290 14 10
ISOSORBIDE MONONITRATE ER 346 344 15 45
SERTRALINE HCL 320 293 16 22
BENAZEPRIL HCL 276 258 17 90
GABAPENTIN 238 182 18 11
DIOVAN 223 213 19 48
TRIAMTERENE-HCTZ 212 210 20 69
CRESTOR 208 173 21 18
NEXIUM 204 167 22 14
METOPROLOL SUCCINATE 199 186 23 12
ALLOPURINOL 198 186 24 38
DONEPEZIL HCL 197 194 25 31
TAMSULOSIN HCL 196 183 26 30
DIGOXIN 193 180 27 46
LOSARTAN POTASSIUM 192 192 28 26
AMLODIPINE BESYLATE-BENAZEPRIL 181 149 29 74
CELEBREX 172 168 30 89
CITALOPRAM HBR 167 151 31 20
ALENDRONATE SODIUM 161 148 32 43
QUINAPRIL HCL 160 135 33 103
ZOLPIDEM TARTRATE 160 129 33 23
PREDNISONE 157 149 35 40
QUETIAPINE FUMARATE 149 147 36 84
RANITIDINE HCL 147 120 37 25
CLOPIDOGREL 146 141 38 24
DIOVAN HCT 142 140 39 126
TRAMADOL HCL 137 110 40 21
ZETIA 136 125 41 66
CARVEDILOL 127 122 42 29
GLYBURIDE 125 111 R 43 85
SYNTHROID 120 118 44 47
VENLAFAXINE HCL ER 119 102 45 97
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 101 45 93
PROPRANOLOL HCL 119 118 45 130
LANTUS 118 79 48 58
LOSARTAN-HYDROCHLOROTHIAZIDE 118 108 48 73
PAROXETINE HCL 116 114 50 52
ENALAPRIL MALEATE 116 116 50 49
LOVASTATIN 116 108 50 44
ESCITALOPRAM OXALATE 100 93 53 78
JANUVIA 99 92 54 53
GLIPIZIDE 99 85 54 67
PRAVASTATIN SODIUM 96 96 56 19
IBUPROFEN 95 74 57 50
BUSPIRONE HCL 93 81 58 124
AZITHROMYCIN 92 82 59 35
TRAZODONE HCL 91 62 60 39
NAMENDA 88 70 61 54
VERAPAMIL ER 88 85 61 94
MIRTAZAPINE 86 82 63 59
LEVEMIR FLEXPEN 85 56 64 177
METFORMIN HCL ER 80 62 65 63
PLAVIX 79 77 66 34
GLIMEPIRIDE 78 78 67 32
ISOSORBIDE DINITRATE 77 75 68 234
PROAIR HFA 77 65 68 28
CLONIDINE HCL 77 66 68 62
PANTOPRAZOLE SODIUM 76 76 71 41
OXYBUTYNIN CHLORIDE ER 75 59 72 148
FAMOTIDINE 74 69 73 99
INSULIN SYRINGE 72 49 74 92
METHOCARBAMOL 72 43 R 74 168
CARBAMAZEPINE 71 64 76 218
LIPITOR 71 64 76 156
PHENYTOIN SODIUM EXTENDED 71 67 76 135
KLOR-CON M20 69 66 79 57
TERAZOSIN HCL 69 69 79 137
LACTULOSE 68 64 81 107
METOCLOPRAMIDE HCL 66 58 82 117
LEVETIRACETAM 66 63 82 152
CIPROFLOXACIN HCL 65 63 84 60
NIFEDIAC CC 64 64 85 346
MECLIZINE HCL 64 64 85 114
AMITRIPTYLINE HCL 62 60 R 87 68
FELODIPINE ER 61 52 88 144
MELOXICAM 60 60 89 33
EXELON 59 59 90 128
OXYCODONE-ACETAMINOPHEN 59 46 S2 90 77
OXYCODONE HCL-ACETAMINOPHEN 59 24 S2 90 71
POLYETHYLENE GLYCOL 3350 58 51 93 79
NYSTATIN-TRIAMCINOLONE 58 57 93 223
LYRICA 58 29 93 65
ALBUTEROL SULFATE 57 57 96 133
NOVOLOG MIX 70-30 57 57 96 249
FENTANYL 57 45 S2 96 76
ACTOS 57 49 96 105
VANCOMYCIN HCL 57 56 96 231
TRICOR 56 40 101 83
SPIRIVA 55 32 102 51
BYSTOLIC 54 54 103 165
NASONEX 53 43 104 240
TORSEMIDE 53 53 104 100
OXYBUTYNIN CHLORIDE 51 47 106 150
EXFORGE 50 35 107 265
VESICARE 50 37 107 263
DESOXIMETASONE 50 48 107 368
MONTELUKAST SODIUM 50 41 107 96
LABETALOL HCL 50 50 107 226
SPIRONOLACTONE 50 45 107 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.